Literature DB >> 21499813

[Old wine in new bottles? The study of Hugosson et al on PSA-based screening].

C Schaefer1, L Weissbach, H H Dubben.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21499813     DOI： 10.1007/s00120-011-2555-1

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  3 in total

1.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

2.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

3.  Trials of prostate-cancer screening are not worthwhile.

Authors:  Hans-Hermann Dubben
Journal:  Lancet Oncol       Date:  2009-03       Impact factor: 41.316
  3 in total
  1 in total

1.  [Urgency after successful treatment of prostate cancer. Prospective study on the influence of treatment modality, morbidity, and epidemiological factors on the quality of life].

Authors:  R Kirschner-Hermanns; T Klementz; A Haselhuhn; G Jakse; A Heidenreich; B Brehmer
Journal:  Urologe A       Date:  2011-11       Impact factor: 0.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.